相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation
Shiguo Zhu et al.
BLOOD (2014)
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
Dagmar Gotthardt et al.
BLOOD (2014)
A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
Thirunavukkarasu Velusamy et al.
BLOOD (2014)
NK cells gain higher IFN-γ competence during terminal differentiation
Merlin Luetke-Eversloh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Evaluation of WO2013125543, WO2013146963 and EP2634185: the first Tyk2 inhibitors from Takeda and Sareum
Peter Norman
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Therapeutic potential of tyrosine kinase 2 in autoimmunity
Yan Liang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Tyk2 is a therapeutic target for psoriasis-like skin inflammation
Masayuki Ishizaki et al.
INTERNATIONAL IMMUNOLOGY (2014)
Role of Type I Interferon Receptor Signaling on NK Cell Development and Functions
Jean Guan et al.
PLOS ONE (2014)
Design of a Peptide Inhibitor of Tyrosine Kinase 2
Melissa G. Works et al.
PROTEIN AND PEPTIDE LETTERS (2014)
Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance
Raimund M. Vielnascher et al.
TRANSGENIC RESEARCH (2014)
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
Dorothy K. Sojka et al.
ELIFE (2014)
Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases
Christel J. Menet
PHARMACEUTICAL PATENT ANALYST (2014)
Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells
Rossana Trotta et al.
BLOOD (2013)
IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
Jeffrey L. Wong et al.
CANCER RESEARCH (2013)
Lead identification of novel and selective TYK2 inhibitors
Jun Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
Hui Peng et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MicroRNA-155 Tunes Both the Threshold and Extent of NK Cell Activation via Targeting of Multiple Signaling Pathways
Ryan P. Sullivan et al.
JOURNAL OF IMMUNOLOGY (2013)
Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent
Zhi Li et al.
JOURNAL OF IMMUNOLOGY (2013)
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy
Chulbul M. Ahmed et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
TYK2-STAT1-BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia
Takaomi Sanda et al.
CANCER DISCOVERY (2013)
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
Eva Maria Putz et al.
CELL REPORTS (2013)
MicroRNA regulation of natural killer cells
Ryan P. Sullivan et al.
FRONTIERS IN IMMUNOLOGY (2013)
Establishing the role of tyrosine kinase 2 in cancer
Caroline Uebel et al.
ONCOIMMUNOLOGY (2013)
miR-155 regulates IFN-γ production in natural killer cells
Rossana Trotta et al.
BLOOD (2012)
Impairment of hepatic NK cell development in IFN-γ deficient mice
Xian Wu et al.
CYTOKINE (2012)
A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome
Sara S. Kilic et al.
JOURNAL OF PEDIATRICS (2012)
TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo
Michaela Prchal-Murphy et al.
PLOS ONE (2012)
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
Tatsuaki Mizutani et al.
ONCOIMMUNOLOGY (2012)
Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
Claude Haan et al.
CHEMISTRY & BIOLOGY (2011)
Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity
Birgit Strobl et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
The Role of Tyk2 in Regulation of Breast Cancer Growth
Qifang Zhang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Next-generation sequencing identifies the natural killer cell microRNA transcriptome
Todd A. Fehniger et al.
GENOME RESEARCH (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
Identification of an Indispensable Role for Tyrosine Kinase 2 in CTL-Mediated Tumor Surveillance
Olivia Simma et al.
CANCER RESEARCH (2009)
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
Eloisi Caldas-Lopes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells
Hisamitsu Ide et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs
Todd A. Fehniger et al.
IMMUNITY (2007)
Developmental pathways that generate natural-killer-cell diversity in mice and humans
Nicholas D. Huntington et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection
Kathleen C. F. Sheehan et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes
Ramesh Potla et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity
Yoshiyuki Minegishi et al.
IMMUNITY (2006)
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2006)
Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation
SH Robbins et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Control of Leishmania major in the absence of Tyk2 kinase
U Schleicher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
TYK2 is a key regulator of the surveillance of B lymphoid tumors
D Stoiber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity
MH Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
M Karaghiosoff et al.
NATURE IMMUNOLOGY (2003)
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression
J Ragimbeau et al.
EMBO JOURNAL (2003)
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice
K Shimoda et al.
BLOOD (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Activating Ly-49 NK receptors: Central role in cytokine and chemokine production
JR Ortaldo et al.
JOURNAL OF IMMUNOLOGY (2001)
Tyk2 plays a restricted role in IFNα signaling, although it is required for IL-12-mediated T cell function
K Shimoda et al.
IMMUNITY (2000)
Distinct requirements for IFNs and STAT1 in NK cell function
CK Lee et al.
JOURNAL OF IMMUNOLOGY (2000)
Partial impairment of cytokine responses in Tyk2-deficient mice
M Karaghiosoff et al.
IMMUNITY (2000)
分享论文
